dr. venook: would you consider another egfr-directed therapy in this patient ?
Published 9 years ago • 18 plays • Length 0:40Download video MP4
Download video MP3
Similar videos
-
0:35
dr. venook: would you consider an egfr-directed therapy, does mutational status matter?
-
1:05
dr. chung: would you consider another egfr-directed therapy in this patient?
-
0:58
dr. chung: would you consider an egfr-directed therapy for this patient?
-
0:50
dr. venook: what are your choices for fourth-line treatment in this patient?
-
0:31
dr. venook: should anti-angiogenesis therapy be continued in this patient?
-
0:39
dr. fakih: considering a second egfr-directed therapy
-
0:26
dr. eng: egfr-directed therapy and mutational status
-
1:05
dr. eng: second egfr-directed therapy and mutational status
-
0:47
dr. venook : what second-line options are available to prolong survival?
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer
-
1:00
venook: what are the principal options to control metastatic disease ?
-
0:48
dr. venook discusses the future of colorectal cancer treatment
-
0:55
dr. venook discusses implications of the calgb/swog 80405 study
-
13:46
choosing between vegf and egfr targeted therapy in mcrc
-
1:27
mariposa: follow-up of lazertinib with amivantamab or osimertinib in egfr-m nsclc
-
1:45
unmet needs and future directions in the treating rare pancreatic cancers
-
49:58
anti egfr therapy in lahnscc- dr cessal thommachan kainickal
-
5:09
egfr therapy as upfront colorectal cancer treatment
-
1:30
overcoming acquired resistance to targeted therapy in colorectal cancer